- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 670579, 7 pages
Possible Influence of Resistance to Malaria in Clinical Presentation of Rheumatoid Arthritis: Biological Significance of Natural Selection
1Division of Rheumatology, Department of Internal Medicine, Fundación Valle del Lili and ICESI University School of Medicine, Cali, Colombia
2Laboratory of Immunorheumatology, Carrera 98 N. 18-49, Cali, Colombia
Received 6 August 2012; Accepted 21 October 2012
Academic Editor: Masami Takei
Copyright © 2012 Fabio Bonilla-Abadía et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. L. Scott, D. P. M. Symmons, B. L. Coulton, and A. J. Popert, “Long-term outcome of treating rheumatoid arthritis: results after 20 years,” The Lancet, vol. 1, no. 8542, pp. 1108–1110, 1987.
- M. Lorenzo, “Rheumatoid arthritis,” Foot and Ankle Clinics, vol. 12, no. 3, pp. 525–537, 2007.
- D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010.
- J. T. Birch Jr. and S. Bhattacharya, “Emerging trends in diagnosis and treatment of rheumatoid arthritis,” Primary Care, vol. 37, no. 4, pp. 779–792, 2010.
- N. King, C. T. Hittinger, and S. B. Carroll, “Evolution of key cell signaling and adhesion protein families predates animal origins,” Science, vol. 301, no. 5631, pp. 361–363, 2003.
- R. Dawkins, The Greatest Show on Earth, Free Press, New York, NY, USA, 2009.
- J. M. Anaya, P. A. Correa, R. D. Mantilla, F. Jimenez, T. Kuffner, and J. M. McNicholl, “Rheumatoid arthritis in African Colombians from Quibdo,” Seminars in Arthritis and Rheumatism, vol. 31, no. 3, pp. 191–198, 2001.
- G. S. Alarcoacuten, “Is rheumatoid arthritis in African descendants from North and South America the same?” Seminars in Arthritis and Rheumatism, vol. 31, no. 3, pp. 143–145, 2001.
- C. A. Cañas and F. Cañas, “The biological significance of evolution in autoimmune phenomena,” Autoimmune Diseases, vol. 2012, Article ID 784315, 12 pages, 2012.
- S. A. Tishkoff and S. M. Williams, “Genetic analysis of African populations: human evolution and complex disease,” Nature Reviews Genetics, vol. 3, no. 8, pp. 611–621, 2002.
- X. I. Pliakou, F. P. Koutsouka, D. Damigos, K. L. Bourantas, E. C. Briasoulis, and P. V. Voulgari, “Rheumatoid arthritis in patients with hemoglobinopathies,” Rheumatology International, vol. 32, no. 9, pp. 2889–2892, 2012.
- G. Min-Oo and P. Gros, “Erythrocyte variants and the nature of their malaria protective effect,” Cellular Microbiology, vol. 7, no. 6, pp. 753–763, 2005.
- T. G. Smith, K. Ayi, L. Serghides, C. D. Mcallister, and K. C. Kain, “Innate immunity to malaria caused by Plasmodium falciparum,” Clinical and Investigative Medicine, vol. 25, no. 6, pp. 262–272, 2002.
- C. López, C. Saravia, A. Gomez, J. Hoebeke, and M. A. Patarroyo, “Mechanisms of genetically-based resistance to malaria,” Gene, vol. 467, no. 1-2, pp. 1–12, 2010.
- A. Driss, J. M. Hibbert, N. O. Wilson, S. A. Iqbal, T. V. Adamkiewicz, and J. K. Stiles, “Genetic polymorphisms linked to susceptibility to malaria,” Malaria Journal, vol. 10, article 271, 2011.
- M. L. Reinagel, M. Gezen, P. J. Ferguson, S. Kuhn, E. N. Martin, and R. P. Taylor, “The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis,” Blood, vol. 89, no. 3, pp. 1068–1077, 1997.
- T. N. Williams, “Red blood cell defects and malaria,” Molecular and Biochemical Parasitology, vol. 149, no. 2, pp. 121–127, 2006.
- V. Thathy, J. M. Moulds, B. Guyah, W. Otieno, and J. A. Stoute, “Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya,” Malaria Journal, vol. 4, article 54, 2005.
- E. Nagayasu, M. Ito, M. Akaki et al., “CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand,” American Journal of Tropical Medicine and Hygiene, vol. 64, no. 1-2, pp. 1–5, 2001.
- J. P. Bayley, T. H. M. Ottenhoff, and C. L. Verweij, “Is there a future for TNF promoter polymorphisms?” Genes and Immunity, vol. 5, no. 5, pp. 315–329, 2004.
- M. Odeh, “The role of tumour necrosis factor-α in the pathogenesis of complicated Falciparum malaria,” Cytokine, vol. 14, no. 1, pp. 11–18, 2001.
- J. C. Knight, I. Udalova, A. V. S. Hill et al., “A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria,” Nature Genetics, vol. 22, no. 2, pp. 145–150, 1999.
- D. Kwiatkowski, “Genetic susceptibility to malaria getting complex,” Current Opinion in Genetics and Development, vol. 10, no. 3, pp. 320–324, 2000.
- P. W. Hedrick, “Population genetics of malaria resistance in humans,” Heredity, vol. 107, pp. 283–304, 2011.
- D. P. Kwiatkowski, “How malaria has affected the human genome and what human genetics can teach us about malaria,” American Journal of Human Genetics, vol. 77, no. 2, pp. 171–192, 2005.
- K. Nistala and K. J. Murray, “Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy,” Journal of Rheumatology, vol. 28, no. 9, pp. 2125–2128, 2001.
- M. R. Clatworthy, L. Willcocks, B. Urban et al., “Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 17, pp. 7169–7174, 2007.
- V. Khurana and T. P. Bradley, “Adult-onset Still's disease associated with G6PD deficiency: a case report and literature review,” Journal of the Association for Academic Minority Physicians, vol. 9, no. 3, pp. 56–58, 1998.
- A. Chatzikyriakidou, P. V. Voulgari, and A. A. Drosos, “What is the role of HLA-B27 in spondyloarthropathies?” Autoimmunity Reviews, vol. 10, no. 8, pp. 464–468, 2011.
- L. M. Gómez, C. Cañas, and J. M. Anaya, “Fcy receptors and autoimmunity,” Acta Médica Colombiana, vol. 30, pp. 27–35, 2005.
- C. Kyogoku, H. M. Dijstelbloem, N. Tsuchiya et al., “Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility,” Arthritis and Rheumatism, vol. 46, no. 5, pp. 1242–1254, 2002.
- U. Siriboonrit, N. Tsuchiya, M. Sirikong et al., “Association of Fcγ receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais,” Tissue Antigens, vol. 61, no. 5, pp. 374–383, 2003.
- M. Waisberg, T. Tarasenko, B. K. Vickers et al., “Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 3, pp. 1122–1127, 2011.
- L. C. Willcocks, E. J. Carr, H. A. Niederer et al., “A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7881–7885, 2010.
- K. G. C. Smith and M. R. Clatworthy, “FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications,” Nature Reviews Immunology, vol. 10, no. 5, pp. 328–343, 2010.
- T. Tiller, J. Kofer, C. Kreschel et al., “Development of self-reactive germinal center B cells and plasma cells in autoimmune FcγRIIB-deficient mice,” Journal of Experimental Medicine, vol. 207, no. 12, pp. 2767–2778, 2010.
- S. K. Nath, J. B. Harley, and Y. H. Lee, “Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis,” Human Genetics, vol. 118, no. 2, pp. 225–234, 2005.
- A. Kumar, A. N. Malaviya, S. Sinha, P. S. Khandekar, K. Banerjee, and L. M. Srivastava, “C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis: low receptor levels on erythrocytes are an acquired phenomenon,” Immunologic Research, vol. 13, no. 1, pp. 61–71, 1994.
- D. Khanna, H. Wu, G. Park et al., “Association of tumor necrosis factor α polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort,” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1105–1116, 2006.
- Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, and G. G. Song, “Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-α-blockers in rheumatoid arthritis: a meta-analysis,” Rheumatology International, vol. 27, no. 2, pp. 157–161, 2006.
- G. J. Graham, M. Locati, A. Mantovani, A. Rot, and M. Thelen, “The biochemistry and biology of the atypical chemokine receptors,” Immunology Letters, vol. 145, no. 1-2, pp. 30–38, 2012.
- S. Hosaka, T. Akahoshi, C. Wada, and H. Kondo, “Expression of the chemokine superfamily in rheumatoid arthritis,” Clinical and Experimental Immunology, vol. 97, no. 3, pp. 451–457, 1994.
- T. Akahoshi, H. Endo, H. Kondo et al., “Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1,” Lymphokine and Cytokine Research, vol. 13, no. 2, pp. 113–116, 1994.
- M. H. Yang, F. X. Wu, C. M. Xie et al., “Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication,” Chinese Medical Sciences Journal, vol. 24, no. 1, pp. 50–54, 2009.
- M. Norii, M. Yamamura, M. Iwahashi, A. Ueno, J. Yamana, and H. Makino, “Selective recruitment of CXCR3+ and CCR5+ CD4+ T cells into synovial tissue in patients with rheumatoid arthritis,” Acta Medica Okayama, vol. 60, no. 3, pp. 149–157, 2006.
- V. Pokorny, F. McQueen, S. Yeoman et al., “Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 3, pp. 487–490, 2005.
- S. K. Lin, H. H. Chang, Y. J. Chen et al., “Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis,” Arthritis and Rheumatism, vol. 58, no. 10, pp. 3145–3156, 2008.
- D. Smolarek, O. Bertrand, M. Czerwinski, Y. Colin, C. Etchebest, and A. G. de Brevern, “Multiple interests in structural models of DARC transmembrane protein,” Transfusion Clinique et Biologique, vol. 17, no. 3, pp. 184–196, 2010.
- A. M. Patterson, H. Siddall, G. Chamberlain, L. Gardner, and J. Middleton, “Expression of the Duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium,” Journal of Pathology, vol. 197, no. 1, pp. 108–116, 2002.
- E. Smith, H. M. McGettrick, M. A. Stone et al., “Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium,” Arthritis and Rheumatism, vol. 58, no. 7, pp. 1968–1973, 2008.
- V. Pittoni, S. Vaglio, L. Magrini et al., “Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease,” Rheumatology International, vol. 23, no. 3, pp. 116–120, 2003.
- M. K. Mannoor, A. Weerasinghe, R. C. Halder et al., “Resistance to malarial infection is achieved by the cooperation of NK1.1+ and NK1.1- Subsets of intermediate TCR cells which are constituents of innate immunity,” Cellular Immunology, vol. 211, no. 2, pp. 96–104, 2001.